A co-stimulatory surface receptor CD137 (4-1BB) was proposed to serve as a biomarker of antigen-specific activation of T cells that enables identification of tumour specific T cells without knowledge of the target antigen [98]. The gene discussed is TNFRSF9; the disease is neoplasm.